Follow POL on Twitter On their 500th post to their excellent weblog. Recent good stuff includes an analysis of the DOJ's position on the application of the False Claims Act to off-label marketing, commentary on the recent Endotech decision, and a rundown of warning causation cases. Come see them speak at AEI on May 21.
Congratulations to Beck and Herrmann
Related Entries:
- An employee's revenge
- "Disclosed to Death"
- "Use of a headset that covers both ears will impair your ability to hear other sounds"
- "Whistle-Blowers' Experiences in Fraud Litigation against Pharmaceutical Companies"
- A $500 million damage award hardly makes news anymore
- Examiner on whistleblower law
- "Obama signs bill amending False Claims Act"
- Katrina whistleblower litigation, cont'd
- After Allison Engine
- Around the Web, May 2
- "The False Claims Act: A Proper Tool for Enforcing Health Care Quality Standards?"
- "False Claims Act Corrections Act"
- Allison Engine podcast
- "Polluting Medical Judgment? False Assumptions in the Pursuit of False Claims Regarding Off-Label Prescribing"
 |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
 |
| Laura Eyi Press Officer, Manhattan Institute leyi@manhattan-institute.org |
